Indianapolis, Indiana — According to state and local economic development sources Roche Diagnostics plans to build out 6,464 square feet of new space in Indianapolis. The company plans to occupy the new space at 9332 Castlegate Dr in Indianapolis, on or about March 1, 2021. According to the company website Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

To learn more about Roche Diagnostics, visit http://www.roche.com/

Company Contact:
Severin Schwan, Chief Executive Officer
severin.schwan@roche.com
317-521-2000

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved